Mirum Pharmaceuticals, Inc. (MIRM)
97.94
+3.94
(+4.19%)
USD |
NASDAQ |
Jun 11, 11:48
Mirum Pharmaceuticals 1 Year Total Returns (Daily) : 91.92% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 91.92% |
| June 09, 2026 | 102.9% |
| June 08, 2026 | 101.8% |
| June 05, 2026 | 109.4% |
| June 04, 2026 | 107.3% |
| June 03, 2026 | 102.8% |
| June 02, 2026 | 100.5% |
| June 01, 2026 | 116.7% |
| May 29, 2026 | 130.7% |
| May 28, 2026 | 127.8% |
| May 27, 2026 | 121.9% |
| May 26, 2026 | 124.8% |
| May 22, 2026 | 123.9% |
| May 21, 2026 | 127.2% |
| May 20, 2026 | 113.8% |
| May 19, 2026 | 113.1% |
| May 18, 2026 | 112.2% |
| May 15, 2026 | 125.7% |
| May 14, 2026 | 150.9% |
| May 13, 2026 | 141.1% |
| May 12, 2026 | 134.5% |
| May 11, 2026 | 139.8% |
| May 08, 2026 | 136.9% |
| May 07, 2026 | 149.7% |
| May 06, 2026 | 168.5% |
| Date | Value |
|---|---|
| May 05, 2026 | 139.7% |
| May 04, 2026 | 142.1% |
| May 01, 2026 | 122.3% |
| April 30, 2026 | 124.0% |
| April 29, 2026 | 121.4% |
| April 28, 2026 | 127.5% |
| April 27, 2026 | 126.7% |
| April 24, 2026 | 126.1% |
| April 23, 2026 | 132.1% |
| April 22, 2026 | 139.2% |
| April 21, 2026 | 143.1% |
| April 20, 2026 | 144.8% |
| April 17, 2026 | 150.5% |
| April 16, 2026 | 147.4% |
| April 15, 2026 | 149.5% |
| April 14, 2026 | 144.8% |
| April 13, 2026 | 143.8% |
| April 10, 2026 | 143.4% |
| April 09, 2026 | 138.6% |
| April 08, 2026 | 149.1% |
| April 07, 2026 | 133.3% |
| April 06, 2026 | 129.0% |
| April 02, 2026 | 109.3% |
| April 01, 2026 | 114.9% |
| March 31, 2026 | 105.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| BioMarin Pharmaceutical, Inc. | -2.28% |
| Incyte Corp. | 50.41% |
| Ionis Pharmaceuticals, Inc. | 99.02% |
| Travere Therapeutics, Inc. | 208.9% |
| Vertex Pharmaceuticals, Inc. | -3.50% |